## Abstract The purpose of this study was to compare the hepatic and small intestinal metabolism, and to examine bioavailability and gastro‐intestinal first‐pass effects, of kaempferol in rats. Liver and small intestinal microsomes fortified with either NADPH or UDPGA were incubated with varying co
Pharmacokinetics and bioavailability of methocarbamol in rats
✍ Scribed by R. Obach; J. Pruñonosa; A. Menargues; M. Nomen; J. Vallès
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 467 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
✦ Synopsis
In a pharmacokinetic study, 15, 30, 60, and 150 mg kg-' intravenous and oral doses of methocarbamol were administered to rats. Differences observed in plasma clearance values, i.e. 0~0203,0~0156,0~0123, and 0-0085 1 kg-' min-' for 15,30,60, and 150 mg kg-', respectively, suggested a dosedependent pharmacokinetic behaviour of the drug. Elimination according to a biocompartmental open model and Michaelis-Menten kinetics fits the plasma level data. Estimated Km and V,,, values were 38-49 k 3-71 mg I-' and 1.24 f 0.06 mg 1-' min-', respectively. After oral administration of 15,30, and 60 mg kg-' the peak plasma levels were reached earlier. The tmax values were 6, 6, and 10 min, respectively. After 150 mg kg-' oral doses, peak plasma levels were reached later (tmax = 150 min). Estimated bioavailability ranged between 77 and 112 per cent.
📜 SIMILAR VOLUMES
The pharmacokinetics of cyanamide after 35 mg kg-' intravenous and oral administration to fasted and unfasted rats have been investigated. The plasma level are fitted well by a two-compartment open model. The half-life ( t l p) of c anamide in the rat was 1 hour and the plasma clearance (Cl,) was 0.
## Abstract The absorption of bromhexine from Bromhexin tablets 8 mg, __DAK__ has been compared with that from Bisolvon® tablets 8 mg, Boehringer Ingelheim, in a two‐way complete crossover study. Four tablets of each of the two bromhexine products, corresponding to a single dose of 32 mg of bromhex
The aim of this investigation was to assess the pharmacokinetics and bioavailability of ergometrine in six human male subjects after an oral dose of 0.200 mg and after an intravenous dose of 0.075 mg of ergometrine maleate. A large variation in bioavailability of between 34% and 117% in the six volu
Stereoselectivity of the pharmacokinetics of the nonsteroidal antiinflammatory drug flobufen, 4-(2Ј,4Ј-difluorobiphenyl-4-yl)-2-methyl-4-oxobutanoic acid, was studied in male Wistar rats after intravenous administration. Pharmacokinetic parameters and chiral inversion of flobufen enantiomers were st